System Transmission

Top Signal

100#1 JOB

Activity

2170Ripe

+926 today

System

Livenow

Terminal Asset View

stockNASDAQ

TBPH

$13.78-0.79%

Theravance Biopharma Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

8Neutral

Live Analysis Active

Company Mission

This company creates medicines for breathing problems such as asthma and COPD. Doctors prescribe these drugs to patients to help them breathe better. It makes money by selling these products and working with bigger drug companies to share profits.

TBP

Industry Context

This company operates in the biopharmaceutical industry, focusing on creating treatments for respiratory conditions like asthma and COPD. It competes by developing novel therapies that target specific pathways, often partnering with larger firms for distribution.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

22Matrix

Market Momentum

26.3— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-0.79%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing TBPH across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:47 AM UTC

As-of As of 2026-03-16T08:32:32.909Z UTC (~15m delay).

Develops and sells drugs for respiratory diseases, earning revenue from product sales and partnerships with larger pharmaceutical companies.

Consolidation on the weekly timeframe signals energy building for the next trend near $15, suggesting bullish momentum as it gathers strength. Watch for a breakout above this level.

Weekly pattern shows consolidation near $15, indicating potential upward movement as buyers accumulate shares. Monitor if it holds above this support.

Consolidation persists around $15, hinting at a breakout as market participants await catalysts. Watch for increased volume to confirm the move.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...